Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Trupanion reports robust 2022 growth, eyes international expansion opportunities

Trupanion delivered strong financial performance in 2022, with significant revenue and income growth driven by pet acquisitions and retention strategies.
The company's focus on efficient capital deployment, expansion into new channels, and cash reserve position it well for future growth and profitability.
While facing challenges from pricing dynamics and international expansion, Trupanion's strategic initiatives present opportunities for sustained growth and market expansion.
With a positive outlook for 2023 and a solid foundation of customer data, Trupanion is poised to leverage its strengths and navigate challenges for continued success.

Trupanion reports robust Q1 earnings, eyes global expansion opportunities

Trupanion's Q1 2023 earnings call showcased strong financial performance, strategic focus on managing challenges related to inflation, and opportunities for global expansion and market growth. The company's effective pricing strategies and emphasis on long-term vision position it well for revenue growth and margin expansion in 2023.

Trupanion reports robust Q2 performance, eyes growth opportunities ahead

Trupanion's Q2 2023 performance reflects strong revenue growth, margin stabilization, and strategic cost management.
The company aims for disciplined growth, margin expansion, and sustained ARPU amidst challenges in revenue diversification and cost optimization.
Opportunities lie in continued rate increases, marketing efficiency improvements, and enhanced reporting for customer engagement and financial performance.

Trupanion reports robust Q3 earnings, eyes disciplined growth strategies

Trupanion's Q3 performance reflects strong revenue growth, margin expansion, and improved cash flow, underpinned by pricing power and customer loyalty.
While facing challenges in diversifying revenue streams and entering new markets, the company is well-positioned to leverage growth opportunities and maintain financial stability.
With a focus on disciplined growth, operational efficiency, and strategic investments, Trupanion aims to sustain positive momentum and capitalize on the growing pet insurance market.

Trupanion reports robust Q4 growth, focuses on margin expansion

Trupanion's Q4 performance reflects resilience amid industry challenges, with a strong focus on sustainable growth and financial discipline. The company's strategic initiatives to enhance member experience, prioritize margin expansion, and optimize capital deployment position it well for future opportunities.

Trupanion reports robust Q1 performance amidst market challenges and opportunities

Trupanion's Q1 2024 performance reflects strong revenue growth, margin expansion, and operational improvements driven by customer-centric strategies and efficient capital deployment.
While facing challenges such as inflation impacts and remediation efforts, the company's focus on margin expansion, market opportunities, and strategic initiatives positions it for future growth.
Investors can be optimistic about Trupanion's ability to navigate challenges, capitalize on growth opportunities, and drive profitability through effective pricing and operational efficiency.

Trupanion reports robust Q3 performance, eyes growth opportunities in Europe

Trupanion's Q3 performance reflects strong growth in subscription income and strategic initiatives to drive profitability and market expansion.
While challenges persist with inflation and cost management, the company's focus on efficiency and growth presents opportunities for sustained success.
Investors should note the positive operational improvements, the strategic market expansion into Europe, and the commitment to achieving sustainable margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Trupanion announced better-than-expected preliminary Q4 2023 results. But the pet insurance company also told investors it expects to report two "material weaknesses" in internal controls when it files its annual report.

Why Trupanion Stock Plummeted Today

OAKLAND, Calif.--(BUSINESS WIRE)---- $TRUP #TRUP--Shares of Trupanion, Inc. (“Trupanion”) dropped over 35% on February 16, 2024, after the company revealed that it “expects to report two material weaknesses in internal controls.” Gibbs Law Group is investigating a potential Trupanion, Inc. Securities Class Action Lawsuit on behalf of shareholders who lost money in Trupanion, Inc. (NASDAQ: TRUP). What Should Trupanion Inc. Investors Do? If you invested in Trupanion, Inc., visit our website by clicking here, or.

Lost Money in Trupanion, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Trupanion, Inc. (TRUP) Q4 2023 Earnings Call Transcript

Subscription revenue growth accelerated while margins continued to expand sequentially Subscription revenue growth accelerated while margins continued to expand sequentially

Trupanion Reports Fourth Quarter & Full Year 2023 Results

SEATTLE--(BUSINESS WIRE)--Trupanion webinar addresses canine respiratory illness.

Trupanion Reconvenes Council on Animal Health; Provides Data-Driven Update on ‘Mystery' Canine Respiratory Illness

SEATTLE, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2023 fourth quarter and full year after the market closes on Thursday, February 15, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.

Trupanion, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Aflac

Employers Hlds

Unum

Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of the Zacks Accident and Health Insurance industry players like AFL, UNM, EIG and TRUP.

4 Accident & Health Insurers to Watch as Underwriting Exposure Increases

Leveraging its database of over three million pets, Trupanion builds on its series to unveil latest canine respiratory health trends with global veterinary authorities Leveraging its database of over three million pets, Trupanion builds on its series to unveil latest canine respiratory health trends with global veterinary authorities

Trupanion Reconvenes Council on Animal Health to Provide Update on ‘Mystery' Canine Respiratory Illness

Bowlero Corp

CompoSecure

MGP Ingredients

Verrica Pharmaceuticals Inc

Westrock Coffee Holdings LLC

Encore Wire

You want potential short-squeeze stocks that could have the bears running for cover? Great, we got ‘em right here!

7 Potential Short-Squeeze Stocks Poised for Rapid Gains

Fisker Inc

When analyzing stock market trends, investors regularly keep an eye on stocks with significant short interest, where the potential for a sudden surge keeps investors on their toes.

Short squeeze alert for January 11th: 2 stocks positioned to surge

Oric Pharmaceuticals

Under most financial guidance frameworks, experts advise a long-term approach, which is exactly the opposite ethos when it comes to speculative ideas for high potential stocks. Here, the emphasis centers on getting in, scalping a quick profit and getting out to advantage the next opportunity.

Final Boarding Call: 3 Stocks Set for a Sky-High Surge

Trupanion Earns Seattle Best Places to Work and Best Large Places to Work on Built In's Best Places to Work List Trupanion Earns Seattle Best Places to Work and Best Large Places to Work on Built In's Best Places to Work List

Built In Honors Trupanion in its Esteemed 2024 Best Places to Work Awards

C3.ai

Biomea Fusion Inc

Beyond Meat

Carvana

Novavax

B. Riley Financial

Frontier Group Holdings

Upstart Holdings

The number of shorted shares has grown 23% since the end of 2020, but that doesn't mean traders are getting more bearish about the market.

Short Sellers Think These Stocks Will Tank in 2024. Investors Can Bet Otherwise.

Arrival Group

Bank of Hawaii

Harrow Health Inc

Omeros

PAR Technology

Theravance Biopharma

While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong. Rather, it's time to address this speculative practice under a three-dimensional lens.

7 Short-Squeeze Stocks That Are Screaming for Speculation

COLUMBUS, Ga. and SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- “Since the establishment of a strategic business alliance in November 2020, Aflac Incorporated and Trupanion have shared a common belief that employers should consider a package of benefits for their employees to address the increasing number of consumers who se pets are a vital part of their families. Our collaboration addresses the growing need for solutions that help pet owners manage rising veterinary care costs. Together, we have launched a suite of high-quality pet medical insurance products available at U.S. worksites. After testing this alignment in Japan, a key market for Aflac, a decision was made to withdraw from development in Japan, and instead the companies are focusing on the larger, underpenetrated North American pet insurance market.”

Statement from Aflac Incorporated and Trupanion Confirming Commitment to Strategic Alliance in North America

COLUMBUS, Ga. and SEATTLE, Dec. 14, 2023 /PRNewswire/ --  "Since the establishment of a strategic business alliance in November 2020, Aflac Incorporated and Trupanion have shared a common belief that employers should consider a package of benefits for their employees to address the increasing number of consumers whose pets are a vital part of their families.

Statement from Aflac Incorporated and Trupanion Confirming Commitment to Strategic Alliance in North America

Trupanion-hosted event reveals 5 key tips for managing pet behavioral health Trupanion-hosted event reveals 5 key tips for managing pet behavioral health

Trupanion, leading pet medical insurance provider, teams up with renowned animal health experts to raise awareness around pet behavioral health

COLUMBUS, Ga. and SEATTLE , Dec. 4, 2023 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL), a Fortune 500 company and leading provider of supplemental health insurance in Japan and the United States, and Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, jointly announce Trupanion's renewal of an S-3 registration statement on December 1, 2023.

Aflac and Trupanion Comment on Renewed S-3 Registration Statement Filed in Accordance with 2020 Shareholder Agreement

SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today hosted an audience of thousands during a live online event, sharing proprietary data and insights in partnership with world-leading animal health experts. The live event was held in rapid response to growing concerns regarding reports of canine respiratory illness broadly circulating in the U.S. and Canada.

Trupanion, leading pet medical insurance provider, shares respiratory health data amid rising Canine Respiratory Illness concerns

Blink Charging

Cava Group, Inc.

Edgewise Therapeutics

Kura Sushi USA

Red Robin

Xponential Fitness

Easily one of the most powerful catalysts in the capital markets, short-squeeze stocks deserve to be on your radar because of their ability to foster panic. Subsequently, this panic forces bearish traders to cover their short positions, in turn making the underlying security rise ever higher.

Speculator's Watch List: 7 Stocks Ripe for a Short-Squeeze Windfall

Trupanion to convene canine respiratory illness Q&A with expert veterinarian panelists live on November 30 Trupanion to convene canine respiratory illness Q&A with expert veterinarian panelists live on November 30

Global Veterinary Authorities Delve into Trupanion Data, Gaining Insight into Current Canine Respiratory Illness Concerns

Groupon

HighPeak Energy Inc

Sonic Automotive

Skillz

VinFast Auto Ltd

Few other phenomena scare bearish traders than an unexpected momentum shift that forces an awful decision, thereby imbuing the concept of short-squeeze stocks with unignorable leverage. After all, when bulls get things wrong, they generally risk their principal.

7 Short-Squeeze Stocks That Could Serve Up Serious Rewards

- Expert panelists to share insights into understanding and managing behavioral health issues in pets - Premiere comes at a time of rising veterinary visits related to behavioral concerns in pets SEATTLE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- As pet parents settle into the school run, work-week routine, Trupanion, the leading insurance provider for cats and dogs, is raising awareness around pet behavioral health, and the potential impact of these transitions on our pets and ourselves. On December 6, 2023, Trupanion will be hosting a YouTube Premiere, “Understanding & Managing Behavioral Health in Pets”.

Supporting Your Pet's Behavioral Health During the Back-to-Office Transition: Join Trupanion's YouTube Premiere for Expert Guidance

SEATTLE, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The holiday season, a period synonymous with joy, merriment, and family gatherings, also presents unique challenges for our beloved pets. As we immerse ourselves in festive activities, Trupanion, the leading provider of pet medical insurance for cats and dogs, aims to shed light on the unique safety considerations for our furry companions during this season.

Trupanion's Holiday Safety Guide: Protecting Your Pets During Festive Seasons

Trupanion has appointed a new Chief Financial Officer, after its former CFO left his position in June this year. Trupanion expects its Subscription Business' operating margin to expand to 15% in Q4 2024, as there is a time lag for pricing actions to take effect. I award a Hold rating to TRUP stock, after assessing the positives associated with the new CFO appointment and the long period of time it takes for meaningful profitability improvement.

News for Trupanion Stock (TRUP)